A population-based cohort study examined the relationship between changes in body mass index (BMI) and prostate cancer risk in 1,332,372 Korean males. The study followed participants from 2009 to 2017, classifying BMI using Asia-Pacific criteria and defining BMI change into 25 groups. Prostate cancer diagnoses were confirmed using ICD-10 codes.
Study Design and Population
The analysis assessed adjusted hazard ratios and 95% confidence intervals to determine associations between BMI trajectories and cancer risk, controlling for demographic, lifestyle, and comorbidity factors. Over a period of 12.7 million person-years, 9,147 prostate cancers were identified.
Key Clinical Findings
Distinct risk patterns were observed based on BMI changes. Remaining underweight or transitioning from underweight to normal BMI was associated with a lower risk. Persistent overweight, persistent obesity I, and transitioning from overweight to obesity I were linked to increased risk. Among males with obesity I, weight loss to normal BMI was associated with a reduced risk compared to persistent obesity I. The study found that persistent obesity II (≥30 kg/m²) was associated with lower risk among males. These findings suggest that the impact of longitudinal adiposity patterns varies by smoking status and age, supporting personalized, lifestage-specific prevention emphasizing weight management and lifestyle modification.